BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15197793)

  • 1. Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma.
    Porter PL; Lund MJ; Lin MG; Yuan X; Liff JM; Flagg EW; Coates RJ; Eley JW
    Cancer; 2004 Jun; 100(12):2533-42. PubMed ID: 15197793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.
    Lund MJ; Trivers KF; Porter PL; Coates RJ; Leyland-Jones B; Brawley OW; Flagg EW; O'Regan RM; Gabram SG; Eley JW
    Breast Cancer Res Treat; 2009 Jan; 113(2):357-70. PubMed ID: 18324472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. African-American/White differences in breast carcinoma: p53 alterations and other tumor characteristics.
    Jones BA; Kasl SV; Howe CL; Lachman M; Dubrow R; Curnen MM; Soler-Vila H; Beeghly A; Duan F; Owens P
    Cancer; 2004 Sep; 101(6):1293-301. PubMed ID: 15368321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 overexpression is associated with estrogen receptor expression in Caucasian but not African-American breast cancer.
    Joe AK; Memeo L; Mckoy J; Mansukhani M; Liu H; Avila-Bront A; Romero J; Li H; Troxel A; Hibshoosh H
    Anticancer Res; 2005; 25(1A):273-81. PubMed ID: 15816548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early onset of breast carcinoma in African American women with poor prognostic factors.
    Aziz H; Hussain F; Sohn C; Mediavillo R; Saitta A; Hussain A; Brandys M; Homel P; Rotman M
    Am J Clin Oncol; 1999 Oct; 22(5):436-40. PubMed ID: 10521053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of ancestral informative markers and self-reported race with tumor characteristics of breast cancer among Black and White women.
    Reding KW; Carlson CS; Kahsai O; Chen CC; McDavid A; Doody DR; Chen C; Ornelas I; Lowe K; Bernstein L; Weiss L; McDonald JA; Simon MS; Strom B; Marchbanks PA; Burkman R; Spirtas R; Liff JM; Malone KE
    Breast Cancer Res Treat; 2012 Jul; 134(2):801-9. PubMed ID: 22648732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women.
    Ferguson NL; Bell J; Heidel R; Lee S; Vanmeter S; Duncan L; Munsey B; Panella T; Orucevic A
    Breast J; 2013; 19(1):22-30. PubMed ID: 23240985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 21-Gene recurrence scores: racial differences in testing, scores, treatment, and outcome.
    Lund MJ; Mosunjac M; Davis KM; Gabram-Mendola S; Rizzo M; Bumpers HL; Hearn S; Zelnak A; Styblo T; O'Regan RM
    Cancer; 2012 Feb; 118(3):788-96. PubMed ID: 21720988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of p21Waf1, p27Kip1 and cyclin D1 proteins in breast ductal carcinoma in situ: Relation with clinicopathologic characteristics and with p53 expression and estrogen receptor status.
    Oh YL; Choi JS; Song SY; Ko YH; Han BK; Nam SJ; Yang JH
    Pathol Int; 2001 Feb; 51(2):94-9. PubMed ID: 11169147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological characteristics of triple-negative invasive mammary carcinomas in African-American versus Caucasian women.
    Tawfik O; Davis K; Kimler BF; Davis MK; Hull S; Fan F; Khan QJ; O'Dea AP; Thomas P
    Ann Clin Lab Sci; 2010; 40(4):315-23. PubMed ID: 20947804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle proteins do not predict outcome in grade I infiltrating ductal carcinoma of the breast.
    Leong AC; Hanby AM; Potts HW; Tan DS; Skilton D; Ryder K; Harris WH; Liebmann RD; Barnes DM; Gillett CE
    Int J Cancer; 2000 Jan; 89(1):26-31. PubMed ID: 10719727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial disparities in female breast cancer in South Carolina: clinical evidence for a biological basis.
    Cunningham JE; Butler WM
    Breast Cancer Res Treat; 2004 Nov; 88(2):161-76. PubMed ID: 15564799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.
    Ma H; Lu Y; Malone KE; Marchbanks PA; Deapen DM; Spirtas R; Burkman RT; Strom BL; McDonald JA; Folger SG; Simon MS; Sullivan-Halley J; Press MF; Bernstein L
    BMC Cancer; 2013 May; 13():225. PubMed ID: 23642215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.
    Elledge RM; Clark GM; Chamness GC; Osborne CK
    J Natl Cancer Inst; 1994 May; 86(9):705-12. PubMed ID: 7908990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic grade, stage, and survival in breast carcinoma: comparison of African American and Caucasian women.
    Henson DE; Chu KC; Levine PH
    Cancer; 2003 Sep; 98(5):908-17. PubMed ID: 12942556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial differences in breast carcinoma survival.
    Joslyn SA; West MM
    Cancer; 2000 Jan; 88(1):114-23. PubMed ID: 10618613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced stages and poorly differentiated grade are associated with an increased risk of HER2/neu positive breast carcinoma only in White women: findings from a prospective cohort study of African-American and White-American women.
    Stark A; Kapke A; Schultz D; Brown R; Linden M; Raju U
    Breast Cancer Res Treat; 2008 Feb; 107(3):405-14. PubMed ID: 17431759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYC amplification in subtypes of breast cancers in African American women.
    Naab TJ; Gautam A; Ricks-Santi L; Esnakula AK; Kanaan YM; DeWitty RL; Asgedom G; Makambi KH; Abawi M; Blancato JK
    BMC Cancer; 2018 Mar; 18(1):274. PubMed ID: 29523126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of triple-negative tumors in an urban cancer center.
    Lund MJ; Butler EN; Bumpers HL; Okoli J; Rizzo M; Hatchett N; Green VL; Brawley OW; Oprea-Ilies GM; Gabram SG
    Cancer; 2008 Aug; 113(3):608-15. PubMed ID: 18484596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base.
    Killelea BK; Yang VQ; Wang SY; Hayse B; Mougalian S; Horowitz NR; Chagpar AB; Pusztai L; Lannin DR
    J Clin Oncol; 2015 Dec; 33(36):4267-76. PubMed ID: 26598753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.